Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC
Clinical trial NCT07172386 · RECRUITING
Trial details
- NCT number
- NCT07172386
- Sponsor
- Tianjin Medical University Second Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-31
- Primary completion
- 2026-07-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.